Brazil scraps Covaxin's EUA application after Bharat Biotech terminates pact with partners
The Hindu
This comes in the backdrop of Brazil suspending the proposed clinical trials of Covaxin
After suspending the proposed clinical trials of Bharat Bioetch’s COVID-19 vaccine Covaxin, Brazil has now scrapped the Emergency Use Authorisation (EUA) request made by the Indian company for the jab. The Brazilian health regulator's decision comes after the vaccine maker informed the South American country about the termination of its pact with its partners in that country. According to a statement issued by the National Health Surveillance Agency of Brazil, Anvisa, its Collegiate Board on July 24 unanimously decided "to close the process that dealt with the temporary authorization of emergency use, on an experimental basis, of the Covaxin vaccine".More Related News